Nuzenio

Break Through Cancer

Break Through Cancer news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 3 latest news signals 3 publisher sources 100/100 entity strength

Latest news

THE LUSTGARTEN FOUNDATION AND BREAK THROUGH CANCER ANNOUNCE NEW CLINICAL TRIAL EVALUATING KRAS-TARGETED IMMUNOTHERAPY STRATEGY FOR PANCREATIC CANCER - PR NewswirePR Newswire · Mon, 10 Aug 2026 13:50:00 GMTLilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer - Eli Lilly and CompanyEli Lilly and Company · Mon, 03 Aug 2026 11:46:30 GMTSpreading Awareness About Ovarian Cancer to Reduce the Risk – Break Through Cancer - OncodailyOncodaily · Thu, 30 Jul 2026 07:00:00 GMT

Timeline

Mon, 10 Aug 2026 13:50:00 GMTTHE LUSTGARTEN FOUNDATION AND BREAK THROUGH CANCER ANNOUNCE NEW CLINICAL TRIAL EVALUATING KRAS-TARGETED IMMUNOTHERAPY STRATEGY FOR PANCREATIC CANCER - PR Newswire
Mon, 03 Aug 2026 11:46:30 GMTLilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer - Eli Lilly and Company
Thu, 30 Jul 2026 07:00:00 GMTSpreading Awareness About Ovarian Cancer to Reduce the Risk – Break Through Cancer - Oncodaily

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Break Through Cancer.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.